{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-25-003205","form_type":"8-K","ticker":"SLXN","cik":"0002022416","company_name":"Silexion Therapeutics Corp","filed_at":"2025-09-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.839781+00:00","generated_at":"2026-05-17T09:01:37.291311+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"low","headline":"Silexion posts updated corporate presentation for H.C. Wainwright conference","bullets":["Updated corporate presentation posted to company website on September 2, 2025.","Presentation to be presented on September 10, 2025 at H.C. Wainwright Global Investment Conference in New York.","No specific financial or clinical data disclosed in the 8-K filing excerpt."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-25-003205","json":"https://secwatch.observer/filing/0001178913-25-003205.json","markdown":"https://secwatch.observer/filing/0001178913-25-003205.md","text":"https://secwatch.observer/filing/0001178913-25-003205.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/0001178913-25-003205-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/zk2533739.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:01:37.291311+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}